CLINT HOWE: Open Payments
NPI 1306437694 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 62 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 15 | $356 |
| Actelion Pharmaceuticals US, Inc. | 10 | $300 |
| United Therapeutics Corporation | 4 | $191 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Merck Sharp & Dohme LLC | 9 | $140 |
| BridgeBio Pharma, Inc. | 5 | $108 |
| ABIOMED | 1 | $94 |
| Baxter Healthcare | 1 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
Products named: AMVUTTRA, UPTRAVI, WAINUA, Attruby, STARLING SYSTEM, OPSYNVI, VERQUVO, Remodulin.
Industry payments across AR — which companies pay providers there.
